I need a 20 slide presentation about gout and pseudogout presented by a rheumatologist for primary car physicians. the goal is to teach how to manage these 2 diseases and include data and guidelines published in the last 5-10 years that supports the guidelines. I am uploading my old talk, but I need to add new references and streamline the appearance of the slides. Please include all patient examples as written in my old presentation the slides should be divided about in 3rds. the first 3rd shoudl be about diagnosis and managemtn of acute gout, including new FDA approval of anakinra for acute flares. teh next 3rd should be about chronic amangement and urate lowering therapy drugs including discussion fo teh black box warning on febuxostat. Include discussion of SLT-2 inhibitors. The last 3rd should be about CPPD emphasizing the treattment guidelines and need for screening for metabolic abnormalities
I need a 20 slide presentation about gout and pseudogout presented by a rheumatologist for primary car physicians. the goal is to teach how to manage these 2 diseases and include data and guidelines published in the last 5-10 years that supports the guidelines. I am uploading my old talk, but I need to add new references and streamline the appearance of the slides. Please include all patient examples as written in my old presentation
the slides should be divided about in 3rds. the first 3rd shoudl be about diagnosis and managemtn of acute gout, including new FDA approval of anakinra for acute flares. teh next 3rd should be about chronic amangement and urate lowering therapy drugs including discussion fo teh black box warning on febuxostat. Include discussion of SLT-2 inhibitors. The last 3rd should be about CPPD emphasizing the treattment guidelines and need for screening for metabolic abnormalities
Created using ChatSlide
This practical update for primary care providers focuses on the management of gout and calcium pyrophosphate dihydrate (CPPD) disease. It covers essential topics such as recognizing gout, treating acute flares, and initiating urate-lowering therapy (ULT) for appropriate patients. Emphasis is placed on early intervention, safe treatment options, and optimizing long-term adherence while managing comorbidities. Additionally, it highlights the importance of distinguishing CPPD from gout and...